title: What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults?
authors: Health Policy, Quality & Informatics Program, Mi-chael E. DeBakey VA Medical Center Health Services Research and Development Center for Innovations; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine; and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart & Vascular Center; Houston, Texas 77030.
authors: Salim S
authors: SS
authors: Virani
mesh_terms: D000328:Adult; D000367:Age Factors; D000572:American Heart Association; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D002784:Cholesterol / Q000097:blood; D019317:Evidence-Based Medicine; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States
chemical_list: D000924:Anticholesteremic Agents; D015415:Biomarkers; D002784:Cholesterol
keywords: Arterial disease, peripheral; atherosclerosis; cholesterol, low-density-lipoprotein; cholesterol, non-high-density-lipoprotein; guidelines, cholesterol-management; hypercholesterolemia; risk calculator; statin therapy, long-term; statins, use of